Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vertex Pharmaceuticals
(NQ:
VRTX
)
417.32
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vertex Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
39
40
Next >
3 Biotech Stocks to Buy for the Next Bull Run: March 2024
March 26, 2024
These biotech stocks to buy are well positioned for growth, and will generate solid returns for investors in the next bull run.
Via
InvestorPlace
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,400 Today
March 25, 2024
Via
Benzinga
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
March 25, 2024
Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.
Via
InvestorPlace
3 Biopharma Stocks Predicted to Soar in Q2 2024
March 20, 2024
These biopharma stocks can produce massive returns for Q2 based on new product releases and international treatment approvals.
Via
InvestorPlace
From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
March 19, 2024
These biotech stocks to buy offer a gateway to long-term gains, on the back of groundbreaking healthcare innovations.
Via
InvestorPlace
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
March 17, 2024
It's always a good time to buy great stocks with excellent prospects.
Via
The Motley Fool
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,500 Today
February 27, 2024
Via
Benzinga
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
March 17, 2024
There's no need for delays in buying these great stocks.
Via
The Motley Fool
Forget Tesla, Buy This Magnificent Healthcare Stock Instead
March 17, 2024
Vertex Pharmaceuticals already has a fantastic business, and it could get much bigger in the future.
Via
The Motley Fool
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.
March 09, 2024
Good news could be in store for all three of these drugmakers.
Via
The Motley Fool
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years
March 08, 2024
Via
Benzinga
The Top 3 Biotech Stocks to Buy in March 2024
March 06, 2024
Although the biotech sector puts the benefits and risks in plain sight, three top biotech stocks to buy shine for investors.
Via
InvestorPlace
3 Biopharma Stocks You Don't Want to Miss in the New Bull Market
March 05, 2024
All three have exciting programs on the way.
Via
The Motley Fool
Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making
March 05, 2024
These three companies represent the world of biotech stocks and offer a unique blend of high risk and potentially high reward.
Via
InvestorPlace
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
March 04, 2024
Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising.
Via
InvestorPlace
ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential
March 04, 2024
Here are three ChatGPT stock predictions for the most unpredictable of biotech stocks that might just have 10x potential.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Editas Medicine Stock Soared as Much as 42% Higher This Week
March 02, 2024
The clinical-stage genome editing company dropped a couple of important announcements for shareholders.
Via
The Motley Fool
3 Magnificent Growth Stocks to Buy in March
March 02, 2024
These three stocks have two important common denominators: the same industry and tremendous growth prospects.
Via
The Motley Fool
Apple Sinks After Wall Street Titan Pulls Magnificent 7 Stock From Conviction List
March 01, 2024
Goldman Sachs is removing Apple from its Conviction List of buy-rated stocks. Looking at the potential reasons why and who replaced the tech giant.
Via
Benzinga
These 4 Stocks Are the "Magnificent Seven" of Healthcare
March 01, 2024
Their growth trajectories aren't as meteoric, but they're still notable.
Via
The Motley Fool
Could These 3 Companies Headline a "Magnificent Seven" of Biotech Stocks?
February 29, 2024
These stocks meet many of the criteria long-term investors look for.
Via
The Motley Fool
Beam Rockets 27%, Hitting A Year High, On Its Efforts To Take On Crispr's New Gene-Editing Drug
February 27, 2024
Both companies are working on treatments for genetic disorders.
Via
Investor's Business Daily
3 Biotech Stocks Bound to Blast Off By 2029
February 27, 2024
Biotech stocks are risky, but rewarding. These three biotechs specifically could see exponential gains in the coming years.
Via
InvestorPlace
Vertex Pharmaceuticals (VRTX) Should Remain Supported
February 27, 2024
Vertex Pharmaceuticals Incorporated (VRTX), is a biotechnology company. It engages in developing & commercializing therapies for treating cystic fibrosis (CF).
Via
Talk Markets
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
February 27, 2024
Vertex shares have climbed almost 50% over the past year.
Via
The Motley Fool
Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices
February 26, 2024
Latest pharmaceutical trends in the U.S. as drug prices surged 35% in 2023. Uncover insights into the industry's focus on rare diseases, escalating costs, and the impact on FDA-approved drugs.
Via
Benzinga
The Ultimate Growth Stock to Buy With $1,000 Right Now
February 26, 2024
The positives are many and the negatives are few with this high-flying stock.
Via
The Motley Fool
2 Stocks That Could Crush the Market in 2024
February 25, 2024
These companies aren't slowing down, and their addressable markets are widening.
Via
The Motley Fool
Three S&P 500 Giants Lead This List Of Stocks Near Buy Points
February 24, 2024
Watch these five stocks, but the market is slightly extended.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
February 23, 2024
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
39
40
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.